Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms

Journal of Genetic Counseling

Volumn 22, Issue 3, 2013, Pages 393-405

  Roberts, Maegan E ^a   Riegert Johnson, Douglas L ^a   Thomas, Brittany C ^b   Thomas, Colleen S ^a   Heckman, Michael G ^a   Krishna, Murli ^a   Dicaudo, David J ^c   Bridges, Alina G ^b   Hunt, Katherine S ^c   Rumilla, Kandelaria M ^b   Cappel, Mark A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Immunohistochemistry; Lynch syndrome; Mismatch Repair Genes; Muir Torre syndrome; Sebaceous neoplasms

Indexed keywords

NUCLEOPOLYHEDROVIRUS;

ADULT; AGED; ARTICLE; BASE MISPAIRING; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUIR TORRE SYNDROME; PEDIGREE; RETROSPECTIVE STUDY; SEBACEOUS GLAND TUMOR; VERY ELDERLY; MUIR-TORRE SYNDROME; SEBACEOUS GLAND NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUIR-TORRE SYNDROME; PEDIGREE; RETROSPECTIVE STUDIES; SEBACEOUS GLAND NEOPLASMS;

EID: 84877926738     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9552-4     Document Type: Review

References (32)

1. Abbas, O., & Mahalingam, M. (2009). Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. Journal of Cutaneous Pathology, 36(6), 613-619.
2. Bonadona, V., Bonaiti, B., Olschwang, S., Grandjouan, S., Huiart, L., Longy, M., et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA: The Journal of the American Medical Association, 305(22), 2304-2310.
3. Cederquist, K., Emanuelsson, M., Goransson, I., Holinski-Feder, E., Muller-Koch, Y., Golovleva, I., et al. (2004). Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. International Journal of Cancer, 109(3), 370-376.
4. Cesinaro, A. M., Ubiali, A., Sighinolfi, P., Trentini, G. P., Gentili, F., & Facchetti, F. (2007). Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer. American Journal of Dermatopathology, 29(4), 351-358.
5. Chhibber, V., Dresser, K., & Mahalingam, M. (2008). MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome. Modern Pathology, 21(2), 159-164.
6. de la Chapelle, A., & Hampel, H. (2010). Clinical relevance of microsatellite instability in colorectal cancer. Journal of Clinical Oncology, 28(20), 3380-3387.
7. Fusaro, R. M., Lynch, H. T., Pester, J., & Lynch, P. M. (1980). Torre's syndrome as phenotypic expression of cancer family syndrome. Archives of Dermatology, 116(9), 986-987.
8. Goodenberger, M., & Lindor, N. M. (2011). Lynch syndrome and MYH-associated polyposis: review and testing strategy. Journal of Clinical Gastroenterology, 45(6), 488-500.
9. Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., et al. (2005). Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). The New England Journal of Medicine, 352(18), 1851-1860.
10. Hampel, H., Frankel, W., Panescu, J., Lockman, J., Sotamaa, K., Fix, D., et al. (2006). Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Research, 66(15), 7810-7817.
11. Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., et al. (2008). Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Journal of Clinical Oncology, 26(35), 5783-5788.
12. Harwood, C. A., Swale, V. J., Bataille, V. A., Quinn, A. G., Ghali, L., Patel, S. V., et al. (2001). An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. The Journal of Investigative Dermatology, 116(2), 246-253.
13. Harwood, C. A., McGregor, J. M., Swale, V. J., Proby, C. M., Leigh, I. M., Newton, R., et al. (2003). High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. Journal of the American Academy of Dermatology, 48(3), 401-408.
14. Lazar, A. J., Lyle, S., & Calonje, E. (2007). Sebaceous neoplasia and Torre-Muir syndrome. Current Diagnostic Pathology, 13(4), 301-319.
15. Lindor, N. M., Burgart, L. J., Leontovich, O., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., et al. (2002). Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. Journal of Clinical Oncology, 20(4), 1043-1048.
16. Lynch, H. T., Lynch, P. M., Pester, J., & Fusaro, R. M. (1981). The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Archives of Internal Medicine, 141(5), 607-611.
17. Lynch, H. T., Fusaro, R. M., Roberts, L., Voorhees, G. J., & Lynch, J. F. (1985). Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. British Journal of Dermatology, 113(3), 295-301.
18. Machin, P., Catasus, L., Pons, C., Munoz, J., Conde-Zurita, J. M., Balmana, J., et al. (2002). Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. Journal of Cutaneous Pathology, 29(7), 415-420.
19. Mathiak, M., Rutten, A., Mangold, E., Fischer, H. P., Ruzicka, T., Friedl, W., et al. (2002). Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. The American Journal of Surgical Pathology, 26(3), 338-343.
20. Molatore, S., Russo, M. T., D'Agostino, V. G., Barone, F., Matsumoto, Y., Albertini, A. M., et al. (2010). MUTYH mutations associated with familial adenomatous polyposis: functional characterization by a mammalian cell-based assay. Human Mutation, 31(2), 159-166.
21. Morales-Burgos, A., Sanchez, J. L., Figueroa, L. D., De Jesus-Monge, W. E., Cruz-Correa, M. R., Gonzalez-Keelan, C., et al. (2008). MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms. Puerto Rico Health Sciences Journal, 27(4), 322-327.
22. Muir, E. G., Bell, A. J., & Barlow, K. A. (1967). Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. British Journal of Surgery, 54(3), 191-195.
23. Mvundura, M., Grosse, S. D., Hampel, H., & Palomaki, G. E. (2010). The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genetics in Medicine, 12(2), 93-104.
24. Pang, S. M., & Chau, Y. P. (2005). Cyclosporin-induced sebaceous hyperplasia in renal transplant patients. Annals of the Academy of Medicine, Singapore, 34(5), 391-393.
25. Plaschke, J., Engel, C., Kruger, S., Holinski-Feder, E., Pagenstecher, C., Mangold, E., et al. (2004). Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Journal of Clinical Oncology, 22(22), 4486-4494.
26. Ponti, G., Losi, L., Di Gregorio, C., Roncucci, L., Pedroni, M., Scarselli, A., et al. (2005). Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer, 103(5), 1018-1025.
27. Popnikolov, N. K., Gatalica, Z., Colome-Grimmer, M. I., & Sanchez, R. L. (2003). Loss of mismatch repair proteins in sebaceous gland tumors. Journal of Cutaneous Pathology, 30(3), 178-184.
28. Singh, R. S., Grayson, W., Redston, M., Diwan, A. H., Warneke, C. L., McKee, P. H., et al. (2008). Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. The American Journal of Surgical Pathology, 32(6), 936-942.
29. South, C. D., Hampel, H., Comeras, I., Westman, J. A., Frankel, W. L., & de la Chapelle, A. (2008). The frequency of Muir-Torre syndrome among Lynch syndrome families. Journal of the National Cancer Institute, 100(4), 277-281.
30. Torre, D. (1968). Multiple sebaceous tumors. Archives of Dermatology, 98(5), 549-551.
31. Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Ruschoff, J., et al. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96(4), 261-268.
32. Vogt, S., Jones, N., Christian, D., Engel, C., Nielsen, M., Kaufmann, A., et al. (2009). Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology, 137(6), 1976-1985 e1971-1910.